These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 7935946

  • 1. [Leprosy in The Netherlands in the period 1970-1991].
    Post E, chin-A-Lien RA, Bouman C, Naafs B, Faber WR.
    Ned Tijdschr Geneeskd; 1994 Sep 24; 138(39):1960-3. PubMed ID: 7935946
    [Abstract] [Full Text] [Related]

  • 2. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY, Wallach D, Spindler E, Pennec J, Cottenot F, Flageul B.
    Int J Lepr Other Mycobact Dis; 1997 Mar 24; 65(1):37-44. PubMed ID: 9207752
    [Abstract] [Full Text] [Related]

  • 3. Epidemiologic characteristics of leprosy reactions.
    Scollard DM, Smith T, Bhoopat L, Theetranont C, Rangdaeng S, Morens DM.
    Int J Lepr Other Mycobact Dis; 1994 Dec 24; 62(4):559-67. PubMed ID: 7868954
    [Abstract] [Full Text] [Related]

  • 4. Unexplained delayed nerve impairment in leprosy after treatment.
    Rosenberg NR, Faber WR, Vermeulen M.
    Lepr Rev; 2003 Dec 24; 74(4):357-65. PubMed ID: 14750581
    [Abstract] [Full Text] [Related]

  • 5. Occurrence and management of leprosy reaction in China in 2005.
    Shen J, Liu M, Zhou M, Wengzhong L.
    Lepr Rev; 2009 Jun 24; 80(2):164-9. PubMed ID: 19743620
    [Abstract] [Full Text] [Related]

  • 6. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
    Becx-Bleumink M, Berhe D.
    Int J Lepr Other Mycobact Dis; 1992 Jun 24; 60(2):173-84. PubMed ID: 1522359
    [Abstract] [Full Text] [Related]

  • 7. Uveitis in leprosy patients who got inactive condition in pre-WHO/MDT era.
    Namisato N, Joko S, Izumi S, Murakai K, Ogawa H.
    Lepr Rev; 1998 Mar 24; 69(1):82-6. PubMed ID: 9628099
    [No Abstract] [Full Text] [Related]

  • 8. Leprosy in the Netherlands. A review of leprosy patients registered at the Department of Dermatology, University of Amsterdam in the years 1972-1976.
    Faber WR.
    Dermatologica; 1979 Mar 24; 158(1):38-45. PubMed ID: 761690
    [Abstract] [Full Text] [Related]

  • 9. Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India.
    Pocaterra L, Jain S, Reddy R, Muzaffarullah S, Torres O, Suneetha S, Lockwood DN.
    Am J Trop Med Hyg; 2006 May 24; 74(5):868-79. PubMed ID: 16687695
    [Abstract] [Full Text] [Related]

  • 10. Lepromatous leprosy in Saudi female from central region.
    al-Majed S.
    J Hyg Epidemiol Microbiol Immunol; 1991 May 24; 35(2):163-6. PubMed ID: 1940331
    [Abstract] [Full Text] [Related]

  • 11. [The frequency of the appearance of perforating foot ulcers in patients with Hansen's disease as a function of treatment with disulone alone or with polychemotherapy].
    Mane I, Grauwin MY, Cartel JL.
    Acta Leprol; 1995 May 24; 9(3):127-31. PubMed ID: 7631583
    [Abstract] [Full Text] [Related]

  • 12. Histoid leprosy: a retrospective study of 40 cases from India.
    Kaur I, Dogra S, De D, Saikia UN.
    Br J Dermatol; 2009 Feb 24; 160(2):305-10. PubMed ID: 19016704
    [Abstract] [Full Text] [Related]

  • 13. Current profile of active leprosy in Greece; a five-year retrospective study (1988-1992).
    Kyriakis KP, Kontochristopoulos GJ, Panteleos DN.
    Int J Lepr Other Mycobact Dis; 1994 Dec 24; 62(4):547-51. PubMed ID: 7868952
    [Abstract] [Full Text] [Related]

  • 14. Risk factors for erythema nodosum leprosum.
    Manandhar R, LeMaster JW, Roche PW.
    Int J Lepr Other Mycobact Dis; 1999 Sep 24; 67(3):270-8. PubMed ID: 10575406
    [Abstract] [Full Text] [Related]

  • 15. Epidemiological characteristics of leprosy reactions: 15 years experience from north India.
    Kumar B, Dogra S, Kaur I.
    Int J Lepr Other Mycobact Dis; 2004 Jun 24; 72(2):125-33. PubMed ID: 15301592
    [Abstract] [Full Text] [Related]

  • 16. Leprosy reactions in postelimination stage: the Bangladesh experience.
    Mowla MR, Ara S, Mizanur Rahman AFM, Tripura SP, Paul S.
    J Eur Acad Dermatol Venereol; 2017 Apr 24; 31(4):705-711. PubMed ID: 27859670
    [Abstract] [Full Text] [Related]

  • 17. [Immuno-allergic accidents with rifamipcin].
    Flageul B, Wagner L, Cottenot F.
    Acta Leprol; 2017 Apr 24; 12(2):71-8. PubMed ID: 12136739
    [Abstract] [Full Text] [Related]

  • 18. Rifampicin-induced erythema nodosum leprosum-like eruption in borderline lepromatous leprosy.
    Karthikeyan K, Thappa DM, Kadhiravan T.
    Indian J Lepr; 2001 Apr 24; 73(2):167-9. PubMed ID: 11579653
    [No Abstract] [Full Text] [Related]

  • 19. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
    Sapkota BR, Shrestha K, Pandey B, Walker SL.
    Lepr Rev; 2008 Dec 24; 79(4):425-8. PubMed ID: 19274989
    [Abstract] [Full Text] [Related]

  • 20. [Current guidelines for leprosy treatment].
    Flageul B.
    Bull Soc Pathol Exot; 2003 Jan 24; 96(5):357-61. PubMed ID: 15015839
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.